Rheumatology: Current Research : Citations & Metrics Report
Articles published in Rheumatology: Current Research have been cited by esteemed scholars and scientists all around the world. Rheumatology: Current Research has got h-index 17, which means every article in Rheumatology: Current Research has got 17 average citations.
Following are the list of articles that have cited the articles published in Rheumatology: Current Research.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
Total published articles |
60 | 56 | 30 | 60 | 41 | 12 | 15 | 19 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 34 | 24 |
Citations received as per Google Scholar, other indexing platforms and portals |
232 | 238 | 254 | 246 | 173 | 150 | 146 | 152 |
| Journal total citations count | 2294 |
| Journal impact factor | 2.82 |
| Journal 5 years impact factor | 3.38 |
| Journal cite score | 3.26 |
| Journal h-index | 17 |
| Journal h-index since 2019 | 12 |
Important citations (516)
Role of adipokines in systemic sclerosis pathogenesis. |
|
Involvement of disabled-2 on skin fibrosis in systemic sclerosis. |
|
Role of adipokines in systemic sclerosis pathogenesis. |
|
Mir-3606-3p inhibits systemic sclerosis through targeting tgf-? type ii receptor. |
|
Emergent nanotherapies in microcrystal-induced arthritis. |
|
Orofacial consequences of systemic sclerosis: a systematic review: |
|
Fecal microbiome differs between patients with systemic sclerosis with and without small intestinal bacterial overgrowth |
|
Detecting gastrointestinal manifestations in patients with systemic sclerosis using anti-gachr antibodies |
|
Linaclotide for the treatment of refractory lower bowel manifestations of systemic sclerosis. |
|
Linaclotide for the treatment of refractory lower bowel manifestations of systemic sclerosis. |
|
Linaclotide for the treatment of refractory lower bowel manifestations of systemic sclerosis. |
|
Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the singapore systemic sclerosis cohort. |
|
Oral lactobacillus species in systemic sclerosis. |
|
Nintedanib in patients with systemic sclerosis-associated interstitial lung disease: a japanese population analysis of the senscis trial. |
|
The efficacy of dietary intervention on gastrointestinal involvement in systemic sclerosis: a systematic literature review. |
|
Effect of probiotics on gastrointestinal symptoms and immune parameters in systemic sclerosis: a randomized placebo-controlled trial. |
|
Nutrition information resources used by people with systemic sclerosis and perceived advantages and disadvantages: a nominal group technique study. |
|
Gsk3787-loaded poly(ester amide) particles for intra-articular drug delivery |
|
Performance of the ucla scleroderma clinical trials consortium gastrointestinal tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis |
|
The intra-articular injection of rankl-binding peptides inhibits cartilage degeneration in a murine model of osteoarthritis |
|